v3.25.1
Consolidated Balance Sheets - USD ($)
Dec. 31, 2024
Dec. 31, 2023
Current Assets    
Cash and cash equivalents $ 3,264,429 $ 20,729,983
Accounts receivable, net 110,574 242,617
Prepaid expenses 338,660 521,370
Other current assets 343,145 360,125
Total Current Assets 4,056,808 21,854,095
Property and equipment, net 4,429,152 5,523,013
Operating lease right-of-use assets 599,816 549,504
Intangible assets, net 313,747 23,886
Total Assets 9,399,523 27,950,498
Current Liabilities    
Accounts payable 2,766,178 3,211,287
Accrued liabilities 3,476,903 3,928,761
Deferred revenue 230,000 106,600
Management and directors' fees payable 30,086 59,625
Current portion of long-term debt 860,223 1,207,007
Warrant liability 97,886 126,649
Current portion of financing lease liabilities 46,737 48,570
Current portion of operating lease liabilities 221,755 199,323
Current portion of grants repayable 60,979 55,855
Total Current Liabilities 7,790,747 8,943,677
Long-term debt, net of current portion 3,952,846 3,624,860
Deferred revenue, net of current portion 22,663,400 22,893,400
Finance lease liabilities, net of current portion 328,338 400,022
Operating lease liabilities, net of current portion 410,686 378,054
Grants repayable, net of current portion 361,242 422,707
Total Liabilities 35,507,259 36,662,720
Stockholders' Deficit    
Common stock Authorized: 175,000,000 shares of common stock, at $0.001 par value Issued and outstanding: 96,097,485 shares and 81,898,321 shares, respectively 96,098 81,898
Additional paid-in capital 204,154,994 194,448,414
Accumulated other comprehensive income 385,631 243,940
Accumulated deficit (229,544,343) (202,576,507)
Total VolitionRx Limited Stockholders' Deficit (24,907,620) (7,802,255)
Non-controlling interest (1,200,116) (909,967)
Total Stockholders' Deficit (26,107,736) (8,712,222)
Total Liabilities and Stockholders' Deficit $ 9,399,523 $ 27,950,498

Source

10-K PDF
XBRL